ResearcherInstituto Ramón y Cajal de Investigación SanitariaNo recent work listed

Susana Rodríguez Martínez

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4548-0602; OpenAlex author ID A5012756084. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper

Papers 1

Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated … Last author DOI 10.1016/j.ejca.2020.07.035 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Manuel Benavides · 1 shared paper, 2020 · strength 0.10
- Paper Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX … DOI 10.1016/j.ejca.2020.07.035 ↗
Alfredo Carrato Mena · 1 shared paper, 2020 · strength 0.10
- Paper Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX … DOI 10.1016/j.ejca.2020.07.035 ↗
Carmen Guillén‐Ponce · 1 shared paper, 2020 · strength 0.10
- Paper Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX … DOI 10.1016/j.ejca.2020.07.035 ↗
Enrique Aranda Aguilar · 1 shared paper, 2020 · strength 0.10
- Paper Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX … DOI 10.1016/j.ejca.2020.07.035 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.